Affinity Asset Advisors’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11M Buy
+450,000
New +$12.5M 0.45% 51

Other funds holding BEAM

Affinity Asset Advisors's BEAM Position: Q3 2026 in Review

Affinity Asset Advisors opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 450,000 shares worth $11M. The stake represents 0.45% of the portfolio and ranks #51 among its holdings.

260 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Affinity Asset Advisors held 450,000 shares of Beam Therapeutics worth $11M as of Q3 2026.
  • Beam Therapeutics was a new Affinity Asset Advisors position in Q3 2026.
  • Beam Therapeutics made up 0.45% of Affinity Asset Advisors's portfolio in Q3 2026, its #51 holding.
  • 260 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.